Seegene Inc (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced on May 16th the signing of a strategic alliance agreement with Springer Nature, the publisher of the prestigious scientific journal, Nature.Sharing common values in Springer Nature's aim to advance discovery and Seegene working towards realizing a world free of diseases provides the basis for a natural alliance..

Seegene Inc（KQ096530）是一家为PCR分子诊断提供全面解决方案的韩国领先公司，于5月16日宣布与著名科学期刊《自然》的出版商Springer Nature签署战略联盟协议。斯普林格自然基金会（Springer Nature）旨在推进发现和Seegene的共同价值观，努力实现一个没有疾病的世界，为建立自然联盟奠定了基础。。

The new alliance will see the two companies use their joint expertise and knowledge to support researchers across the global scientific community to speed up PCR diagnostic testing of important but various disease areas.

新的联盟将看到两家公司利用其共同的专业知识和知识，支持全球科学界的研究人员，加快对重要但多样的疾病领域进行PCR诊断测试。

PCR molecular diagnostics companies develop only a few diagnostic products annually. By leveraging the Springer Nature network, the two companies will provide funding and technology to global scientists and experts in various fields, significantly broadening the range and potential of diagnostic products.

PCR分子诊断公司每年仅开发少数诊断产品。通过利用Springer Nature网络，两家公司将为各个领域的全球科学家和专家提供资金和技术，大大拓宽诊断产品的范围和潜力。

This initiative, spearheaded by senior management at both companies, builds upon the success of the Open Innovation Program that was launched by the two companies in 2023 whose goal was to develop innovative diagnostic products with participation of the scientific community.Both companies will expand their collaboration using the OneSystem™ business by identifying and promoting potential partners as well as co-hosting annual symposiums starting with a joint declaration this year. 'We are thrilled to deepen our strategic relationship with Springer Nature, an authoritative leader in the global scientific community,' said Dr.

这项由两家公司的高级管理层牵头的举措，以两家公司于2023年启动的开放式创新计划的成功为基础，该计划的目标是在科学界的参与下开发创新的诊断产品。两家公司将利用OneSystem™业务扩大合作，确定和推广潜在合作伙伴，并从今年的联合声明开始共同主办年度研讨会。斯普林格博士说，我们很高兴能够加深与全球科学界权威领导者斯普林格·自然（Springer Nature）的战略关系。

Jong-Yoon Chun, CEO and Founder of Seegene. 'Together, we will work to advance the success of the SG OneSystemTM business and to realize 'a world free of diseases'.''Springer Nature applauds Seegene's effort to democratize early diagnosis of multiple diseases to enable timely treatment,' said Frank Vrancken Peeters, CEO of Springer Nature. 'This noble goal can only be achieved through collaborations.

Seegene首席执行官兼创始人钟尹春（JongYoon-Chun）我们将共同努力，推动SG OneSystemTM业务的成功，并实现“一个没有疾病的世界”Springer Nature首席执行官弗兰克·弗兰肯·佩特斯（FrankVranckenPeeters）说，斯普林格自然（Springer Nature）赞扬Seegene努力使多种疾病的早期诊断民主化，以便及时治疗。“只有通过合作才能实现这一崇高目标。

As a trusted partner to the research community, Springer Nature will help to build a global network of experts who, using Seegene's technology, can accelerate the development of new tests for a wide range of conditions.'Seegene and Springer Nature received significant interest from the global scientific community for the inaugural Open Innovation Program launched in 2023.

作为研究界值得信赖的合作伙伴，Springer Nature将帮助建立一个全球专家网络，利用Seegene的技术，可以加速针对各种条件的新测试的开发。”Seegene和Springer Nature因2023年启动的首届开放创新计划而受到全球科学界的极大关注。

The program, comprising 15 projects, received a total of 281 applications from 47 c.

该项目由15个项目组成，共收到来自47个c的281份申请。